We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Regulatory Readiness: Tips for Surviving Surveys and Staying in Compliance

By CLN Stat
Posted on 14 Dec 2020
Veteran accreditation insiders detail solutions for common deficiencies, pathway to improving quality of care.

An interactive scientific session at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo addresses the most common concerns cited across accrediting agencies that lead to noncompliance in laboratory medicine. More...
Speakers plan to focus on competency assessment, one of the most common areas of citation.

Are You Meeting All the Regulatory Requirements? A Survival Guide for Laboratory Compliance takes place December 14 from 2 to 4:30 p.m. Central Standard Time. It’s worth 2 ACCENT credit hours.

Elia Mears, MS, MT (ASCP)SM, a lab surveyor for The Joint Commission, will discuss the quest for laboratory quality through competency assessment. Attendees will learn how to use regulatory assessment criteria to evaluate competency, identify those qualified to perform the assessment, and integrate the competency assessment program into their lab’s quality assessment plan, Mears told CLN Stat. She’ll also inform attendees about how to build a more robust competency assessment program. “Understanding CLIA roles is critical in the functioning of the laboratory,” she emphasized.

Brad Karon, MD, PhD, a professor of laboratory medicine and pathology at the Mayo Clinic, follows with a talk on the most common lab accreditation citations in the College of American Pathologists’ (CAP) accreditation program and ways to prevent common citations.

No matter how simple the lab test, errors can occur if it’s not performed correctly, leading to significant patient harm, Mears said. “Competency assessment is a focused approach to achieve confirmation that personnel training is effective and established procedures are followed, producing quality results.”

Specific educational requirements apply to personnel conducting lab tests under CLIA, noted Mears. “The exception is waived testing, which may be performed by anyone, following manufacturer instructions and good laboratory practice. For nonwaived testing, specific personnel roles, qualifications, and responsibilities are defined in the Federal Register Subpart M. Understanding the requirements as outlined in Subpart M may be confusing,” she noted.

Delegation of duties is a common area where labs fail, said Karon, who sits on CAP’s Continuous Compliance Committee, which sets requirements for labs to do proficiency testing (PT). This involves understanding which elements of the quality system have been delegated to which CLIA roles and making sure that delegated duties are carried out, he added. Reviewing PT results and corrective action for any missed PT challenges is another area cited often by regulatory and accrediting agencies.

Having a robust competency assessment program is essential, “especially for labs and hospitals with large point-of-care testing programs where many testing personnel are outside the walls of the conventional laboratory,” added Karon.

Participants will gain an understanding of how the CAP Laboratory Accreditation Program helps labs prevent common errors and quality gaps in the laboratory.

Related Links:
2020 AACC Annual Scientific Meeting
Are You Meeting All the Regulatory Requirements? A Survival Guide for Laboratory Compliance


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated Immunoassay Analyzer
SuperFlex™
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.